{"altmetric_id":7121802,"counts":{"readers":{"mendeley":13,"citeulike":1,"connotea":0},"total":{"posts_count":1},"news":{"unique_users_count":1,"unique_users":["oncology_nurse_advisor"],"posts_count":1}},"citation":{"authors":["Carrick S","Parker S","Thornton CE","Ghersi D","Simes J","Wilcken N","Carrick, Sue","Parker, Sharon","Thornton, Charlene E","Ghersi, Davina","Simes, John","Wilcken, Nicholas"],"doi":"10.1002\/14651858.cd003372.pub3","first_seen_on":"2016-05-03T07:08:14+00:00","handle":"1959.7\/502292","handles":["1959.7\/502292"],"isbns":[],"issns":["1465-1858"],"last_mentioned_on":1462195027,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19370586","https:\/\/doi.org\/10.1002\/14651858.cd003372.pub3"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/14651858.CD003372.pub3\/pdf","pmid":"19370586","pubdate":"2009-04-14T23:00:00+00:00","publisher":"Wiley-Blackwell","subjects":["healthservicesresearch","medicine"],"title":"Single agent versus combination chemotherapy for metastatic breast cancer","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/single-agent-versus-combination-chemotherapy-metastatic-breast-cancer-11"},"altmetric_score":{"score":7,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":7},"context_for_score":null},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Doctoral Student":1,"Researcher":2,"Student  > Ph. D. Student":2,"Student  > Postgraduate":2,"Other":2,"Student  > Master":1,"Student  > Bachelor":2,"Lecturer > Senior Lecturer":1},"by_discipline":{"Engineering":1,"Medicine and Dentistry":7,"Agricultural and Biological Sciences":2,"Biochemistry, Genetics and Molecular Biology":2,"Unspecified":1}}}},"posts":{"news":[{"title":"A Review of Systemic Treatment in Metastatic Triple-Negative Breast Cancer","url":"http:\/\/www.oncologynurseadvisor.com\/a-review-of-systemic-treatment-in-metastatic-triple-negative-breast-cancer\/article\/493356\/","license":"public","citation_ids":[4966295,3923455,3923455,7121791,7121792,617074,617074,724678,724678,7121794,7121795,7121796,1988471,512200,7121800,7121802,7121803,1359370,3096223,7121808,210512,210512,7121812,512238,7121814,4122538,4122538,7121816,1193609,2983403,517781,3092076,3092076,7121819,7121820,7121821,7121822,7121823,7121824,7121825,7121826,868948,868948,7121828,7121829,7121830,7121832,7121834,7121836,7121837,7121841,7121842,7121843,7121844,7121846,7121847,7121848,7121849,7121850,2949152,7121851,2492718,3447625,7121855,654504,147615,7121860,193458,193458,791850,791850,432298,2607210,1871996,410500,104178,4531397,4531397,2728335,7121871,7121871,2338277,2338277,7121873,2115433,2115433,1309542,1309542,7121874,2861399,2861399,4469166,4469166,1025306,1025306,6057241,6057241,6091163,6091163,1798171,742634,7121891,2707642,2707642,7121896,3935288,2589414,2589414,1241731,2712027,750270,7121906,7121908,3914960,186456,186456,5425815,5425815,6085338,6085338],"posted_on":"2016-05-02T13:17:07+00:00","summary":"May 02, 2016 the ONA take: Approximately 246 660 patients are expected to receive a diagnosis of breast cancer in the United States in 2016.","author":{"name":"Oncology Nurse Advisor ","url":"http:\/\/www.oncologynurseadvisor.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/001\/276\/normal\/Screen_Shot_2014-11-20_at_11.19.42.png?1416482413"}}]}}